Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Klabunde T, Wendt KU, Kadereit D, Brachvogel V, Burger HJ, Herling AW, Oikonomakos NG, Kosmopoulou MN, Schmoll D, Sarubbi E, von Roedern E, Schönafinger K, Defossa E.
Klabunde T, et al. Among authors: brachvogel v.
J Med Chem. 2005 Oct 6;48(20):6178-93. doi: 10.1021/jm049034y.
J Med Chem. 2005.
PMID: 16190745